Evidence map›Paper›PMID 30143933›Full record

ArticleInflammation2018

Ferulic Acid Protected from Kidney Ischemia Reperfusion Injury in Mice: Possible Mechanism Through Increasing Adenosine Generation via HIF-1α.

Qin Zhou, Xia Gong, Ge Kuang, Rong Jiang, Tianjun Xie, HongTao Tie, XiaHong Chen, Ke Li, JingYuan Wan, Bin Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Plants with Therapeutic Potential for Ischemic Acute Kidney Injury: A Systematic Review.Evidence-based complementary and alternative medicine : eCAM · 2022
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Qin ZhouDepartment of Anesthesiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Xia GongDepartment of Anatomy, Chongqing Medical University, Chongqing, 400016, China.
Ge KuangDepartment of Pharmacology, Chongqing Medical University, Chongqing, 400016, China.
Rong JiangLaboratory of Stem Cell and Tissue Engineering, Chongqing Medical University, Chongqing, 400016, China.
Tianjun XieDepartment of Pharmacology, Chongqing Medical University, Chongqing, 400016, China.
HongTao TieDepartment of Cardiothoracic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
XiaHong ChenDepartment of Pharmacology, Chongqing Medical University, Chongqing, 400016, China.
Ke LiDepartment of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
JingYuan WanDepartment of Pharmacology, Chongqing Medical University, Chongqing, 400016, China. jywan@cqmu.edu.cn.
Bin WangDepartment of Anesthesiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. 13637815096@163.com.
Chongqing Medical University · CNFirst Affiliated Hospital of Chongqing Medical University · CN

Funding

the National Natural Science Foundation of China 81200540
6 · The paper itself

Abstract

Ferulic acid (FA), derived from fruits and vegetables, is well-known as a potent antioxidant of scavenging free radicals. However, the role and underlying mechanism of FA on kidney ischemia reperfusion (I/R) injury are limited. Here, we explored the effects of FA on kidney I/R injury. The kidney I/R injury models were carried out by clamping bilateral pedicles for 35 min followed by reperfusion for 24 h. Mice were orally pretreated with different doses of FA for three times 24 h before I/R. The renal function was assessed by serum creatine (Scr) and blood urea nitrogen (BUN). Kidney histology was examined by hematoxylin and eosin (HE) staining and terminal deoxynucleotidly transferased UTP nick-end labeling (TUNEL) assay. Proinflammatory cytokines, caspase-3 activity, adenosine generation, adenosine signaling molecules, and hypoxia inducible factor-1 alpha (HIF-1α) were also detected, respectively. The siHIF-1α adenovirus vectors were in vivo used to inhibit the expression of HIF-1α. The results showed that FA significantly attenuated kidney damage in renal I/R-operated mice as indicated by reducing levels of Scr and BUN, ameliorating renal pathological structural changes, and tubular cells apoptosis. Moreover, FA pretreatment inhibited I/R-induced renal proinflammatory cytokines and neutrophils recruitment. Interestingly, the levels of HIF-α, CD39, and CD73 mRNA and protein as well as adenosine production were all significantly increased after FA pretreatment in the kidney of I/R-performed mice, and inhibiting HIF-α expression using siRNA abolished this protection of FA on I/R-induced acute kidney injury as evidenced by more severe renal damage and reduced adenosine production. Our findings indicated that FA protected against kidney I/R injury by reducing apoptosis, alleviating inflammation, increasing adenosine generation, and upregulating CD39 and CD73 expression, which might be mediated by HIF-1α.

Indexed as

Reperfusion Injury5'-NucleotidaseAdenosineAnimalsAntigens, CDApoptosisApyraseCoumaric AcidsHypoxia-Inducible Factor 1, alpha SubunitInflammationKidneyMiceProtective Agents5'-NucleotidaseAdenosineAntigens, CDApyraseCD39 antigenCoumaric Acidsferulic acidHypoxia-Inducible Factor 1, alpha SubunitProtective Agentsadenosineferulic acidHIF-1αrenal ischemiareperfusion injury

Identifiers

PMID30143933
OpenAlexW2888373402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.